AdvaMed: MDUFMA III “Isn’t Your Father’s User Fee Agreement”
The FDA user fee bill, which passed a final regulatory hurdle in the Senate Tuesday night, is a three-way win for patients, medical device makers and the FDA, industry lobby AdvaMed’s president & CEO Stephen Ubl said. MassDevice